VVOS logo

Vivos Therapeutics (VVOS) Company Overview

Profile

Full Name:

Vivos Therapeutics, Inc.

Sector:

Healthcare

Country:

United States

IPO:

December 11, 2020

Indexes:

Not included

Description:

Vivos Therapeutics, through its brand VVOS, focuses on developing innovative treatments for sleep apnea and other sleep-related disorders. The company offers non-invasive solutions that aim to improve patients' breathing and overall sleep quality, using advanced technology and personalized care approaches.

Key Details

Price

$3.00

Annual Revenue

$13.80 M(-13.87% YoY)

Annual EPS

-$11.14(+56.99% YoY)

Annual ROE

-521.22%

Beta

0.65

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 27, 2023

Analyst ratings

Recent major analysts updates

Nov 20, 24 Ascendiant Capital
Buy
Nov 19, 24 Alliance Global Partners
Buy
Aug 20, 24 Ascendiant Capital
Buy
Jan 17, 23 Ascendiant Capital
Buy
Aug 13, 21 Roth Capital
Buy
May 18, 21 Roth Capital
Buy
Jan 11, 21 Craig-Hallum
Buy
Jan 5, 21 Roth Capital
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Vivos Therapeutics?
  • Does Vivos Therapeutics pay dividends?
  • What sector is Vivos Therapeutics in?
  • What industry is Vivos Therapeutics in?
  • What country is Vivos Therapeutics based in?
  • When did Vivos Therapeutics go public?
  • Is Vivos Therapeutics in the S&P 500?
  • Is Vivos Therapeutics in the NASDAQ 100?
  • Is Vivos Therapeutics in the Dow Jones?
  • When was Vivos Therapeutics's last earnings report?
  • When does Vivos Therapeutics report earnings?
  • Should I buy Vivos Therapeutics stock now?

What is the ticker symbol for Vivos Therapeutics?

The ticker symbol for Vivos Therapeutics is NASDAQ:VVOS

Does Vivos Therapeutics pay dividends?

No, Vivos Therapeutics does not pay dividends

What sector is Vivos Therapeutics in?

Vivos Therapeutics is in the Healthcare sector

What industry is Vivos Therapeutics in?

Vivos Therapeutics is in the Medical Devices industry

What country is Vivos Therapeutics based in?

Vivos Therapeutics is headquartered in United States

When did Vivos Therapeutics go public?

Vivos Therapeutics's initial public offering (IPO) was on December 11, 2020

Is Vivos Therapeutics in the S&P 500?

No, Vivos Therapeutics is not included in the S&P 500 index

Is Vivos Therapeutics in the NASDAQ 100?

No, Vivos Therapeutics is not included in the NASDAQ 100 index

Is Vivos Therapeutics in the Dow Jones?

No, Vivos Therapeutics is not included in the Dow Jones index

When was Vivos Therapeutics's last earnings report?

Vivos Therapeutics's most recent earnings report was on Nov 14, 2024

When does Vivos Therapeutics report earnings?

The next expected earnings date for Vivos Therapeutics is Mar 28, 2025

Should I buy Vivos Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions